Neopterin is one of biochemical markers of immune activity, which seems to be useful in monitoring inflammatory diseases. Increased serum concentration of neopterin is observed in conditions with cell-mediated immune response involvement. In clinical practice, neopterin evaluation is applied in medical conditions such as: infectious diseases, oncology, rheumatology, transplantology, transfusiology, cardiology, neurology and many others. Neopterin can be detected in serum, urine, cerebrospinal fluid, synovial fluid, saliva, ascitic fluid, bile, pancreatic juice and gastric juice. In recently published studies, various non-specific indicators of inflammation such as neopterin, C-reactive protein, procalcitonin were compared and proved to be independently useful.
Introduction
The clinical value of the indicators of the immune system activity is still being explored in both theoretical and practical scientific studies. Neopterin is one of biochemical markers of immune activity, which seems to be useful in monitoring inflammatory diseases. Increased concentration of neopterin in serum is observed in conditions with involvement of cellmediated immune response. Although, neopterin has been evaluated in many medical conditions, there are still only few reports concerning pediatric population. In recently published studies various non-specific indicators of inflammation such as neopterin, C-reactive protein and procalcitonin were compared. It was concluded that these markers are equally useful in practice (1-3).
Synthesis of neopterin
Neopterin belongs to the chemical group of pyrazino-pyrimidino compounds named pteridines. Their discovery dates back to 1889, when Hopkins isolated yellow pigment of lepidopteran butterfly wing (3). Fifty years later it was named pteridine (pteron = wing). In 1963, neopterin -another member of this biochemical group was isolated (4).
It is well known that pteridine pigments are present not only in insects but also in amphibians, reptiles and fish. However, in other species, especially in mammals, they are observed in relatively small quantities. Biopterin was identified in 1956 in human urine followed by discovery of neopterin in 1967 (5). In 1971 Wachter et al. found that the urine of patients with malignant tumors is reach of fluorescent components identical to neopterin (6). Moreover, these authors proved its presence in elevated concentrations in the urine of people with viral infections (7). In the early 80ies neopterin was described as a biochemical indicator of cell-mediated immune response in humans (8).
Other studies provided data that monocytes/macrophages synthesize neopterin (9) and that neopterin derives from guanosine triphosphate (GTP). The increase of neopterin concentrations can be observed in human serum, when cell-mediated immune response is activated. Specifically Th1 cells release the cytokine interferon-γ (IFN-γ), which stimulates monocytes/macrophages to neopterin synthesis and excretion (9) (Figure 2 ).
Chemical properties of neopterin
Neopterin is characterized by an aromatic ring structure of molecular mass as low as 253 D. This compound is strongly fluorescent, contrary to its derivatives: 7,8-dihydroneptherin or 5,6,7,8-tetrahydroneopterin. Neopterin may be present in the form of various stereoisomers. By far, the most common biological form is 6-D-erythro-neopterin, whereas 6-Dthreo-neopterin (monapterin) occurs only in smaller amounts. Neopterin is excreted via the kidneys in unchanged form. It has been established that under the sunlight neopterin is degraded.
Methods of neopterin detection
There are different methods allowing the detection of neopterin in various fluids."High-performance" liquid chromatography (HPLC) can be combined with a fluorescence to detect neopterin (10) . This method is particularly useful for detection of neopterin in urine However, applying HLPC for determining the concentration of neopterin in serum involves some difficulties associated mainly with lower (about 200 times) concentration in blood in comparison to the urine. In addition, various proteins present in serum need to be separated before HPLC can be performed. However, in case when acidic conditions are used for protein precipitation, this can contribute to a significant oxidation of 7,8-dihydroneopterin and an additional formation of neopterin so that the resulting total neopterin concentrations can substantially increase and are often irreproducible (11) . Therefore it is recommended to rely on the measurement of native neopterin concentrations achieving protein precipitation by acetonitrile (12) . Only when unwanted oxidation of 7,8-dihydroneopterin is avoided, results of HPLC measurements correspond well with measurements done by immunoassays such as ELISA or RIA (described below).
Recently an HPLC method was improved with electrochemical and fluorescence detectors and was successfully used to determine the concentration of neopterin in the cerebrospinal fluid (CSF) (13) .
Radioimmunoassay (RIA). The essence of this method is the competition between neopterin and iodine 125-labeled neopterin for binding sites on specific antibodies. This method allows the accurate evaluation of serum concentrations of neopterin, however, involves the contact with radioactive substances. Enzyme-linked immunosorbent assay (ELISA) is based on the coated plates techniques. This method (ELISA) is considered to be the most modern, relatively simple and reliable one.
Neopterin can be measured in serum/plasma, urine, cerebrospinal fluid (CSF), synovial fluid, saliva, ascitic fluid, bile, pancreatic juice and gastric juice. Determinations of neopterin in the feces (14) and even in the aqueous humor of the eye anterior chamber (15) have also been reported.
Moreover, Polish researchers (16), as others, have attempted to determine neopterin levels in bronchoalveolar lavage-fluid (BALF).
The role of neopterin
The role of neopterin and its derivatives, as well as their biological function, has not yet been fully understood and explained. In recent years it has been proved that there is a relationship between the production of neopterin (and so its derivatives) and the cytotoxic capacity of macrophages. Phagocytes, especially macrophages, kill microbes intracellularly by means of both aerobic and anaerobic processes. The increase in neopterin secretion is associated with enhanced production of reactive oxygen species and low levels of antioxidants in the serum. Therefore, neopterin production may also indirectly reflects oxidative stress intensity (17) (18) (19) (20) (21) .
Reference values of neopterin concentrations in serum of healthy individuals
There is no consensus on reference values of neopterin concentrations in healthy individuals. According to different authors, discrepancies relate to changes of neopterin concentration with age and gender.
Currently available data imply that in 97.2% of healthy population (both children and adults) neopterin concentration in serum is below 10 nmol/L. Therefore, generally the value of 10 nmol/L is estimated as a standard reference concentration of neopterin in serum. However, the manufacturers recommend to validate the reference ranges for each laboratory (10, 22, 23) .
It must be noted that there are only few reports on reference values of serum neopterin concentrations in children and adolescents.
Reference values of concentration of neopterin in serum, according to different studies, are presented in Table 1 . 18 11 Neopterin concentration in urine is usually expressed as mol neopterin/mol creatinine. Neopterin is excreted in unchanged form via kidneys (both glomerular filtration and tubular transport) (28) , so in patients with impaired renal function, one can observe an increase in serum concentrations of neopterin. It has been reported that the ratio of the neopterin/creatinine in urine is dependent on age and gender. Reibnegger et al. studied neopterin concentrations in urine in children and found the highest values in newborns (Table 2 ) (29) . In this research, however, gender differences were not considered.
In different studies it has been observed that the ratio of the neopterin/creatinine in the urine decreases with age. The lowest values are achieved in the age of 25-35 years, and then again increase with age. The lower values of neopterin/creatinine are observed in men compared to women of the same age (18) . It is assumed that the average concentration of neopterin in the urine is as high as 115 ± 36 µmol neopterin/mol creatinine in healthy men, whereas 140 ± 40 µmol neopterin/mol creatinine in females. According to some authors the relation between age and mol neopterin/mol creatinine ratio in the urine may be associated with changing levels of creatinine in urine depending on age (30) .
The reference value of concentration of neopterin in CSF in adults was determined as 4.2 ±1.0 nmol/L (18). According to Millner et al, in children aged 4 to 18 years, with no symptoms of central nervous system (CNS) infection, neopterin concentration in CSF did not exceed 9.3 nmol/L (22) . In other study, Ormazabal did not find any correlation between neopterin concentrations in the CSF and the age of children (13) .
The concentrations of neopterin were also studied in other human fluids. In saliva, the values ranged from 0.2 to 3.4 nmol/L (18, 31) , in synovial fluid from 1 to 9 nmol/L whereas in the ascitic fluid they ranged from 5.3-26.3 nmol/L, and in bronchoalveolar lavage fluid from 45.4 nmol/L to 85.6 nmol/L (16).
Clinical importance of evaluation of the concentration of neopterin Infections
The first observations of increased neopterin excretion with the urine of people suffering from viral infection, were made by Wachter et al in 1979 (7). Since then, many studies confirmed the role of neopterin as an useful marker in differentiating viral from bacterial infections (32, 33) . Cell-mediated immune response is especially activated during infections caused by viruses, intracellular bacteria, parasites and fungi.
Extremely high concentrations of neopterin in serum and urine were observed during acute viral infection in opposite to acute bacterial infection, when the concentrations of neopterin were within the normal ranges or only slightly elevated. However, in chronic bacterial infection the level of neopterin may also be elevated (18) . 
Viral infections
The increase in neopterin concentration was observed in patients with many viral infections such as: acute hepatitis (32, 34, 35) , rubella (36) , measles (37) , cytomegalia (38) , mumps, chicken pox, influenza (39) , and mononucleosis (17, 18) .
Similarly, Denz et al. described extremely high concentrations of neopterin in all studied patients with acute viral infection (hepatitis A, respiratory infections, diarrhea), and normal or only slightly elevated levels in patients with acute bacterial infection (pneumonia) (32) . In the course of acute viral infection neopterin concentration increases prior to the onset of initial symptoms, reaching the highest values before specific antibodies are detectable (40) . After seroconversion, neopterin levels normalize within few days, which usually takes place 2-4 weeks after the peak value (17, 18) . No significant differences in the concentrations of neopterin between infections of DNA and RNA virus etiology were observed (36, 41) .
The greatest clinical usefulness of neopterin was found in human immunodeficiency virus type 1 (HIV-1) infection. The authors reported that at the beginning of HIV-1 infection, in all patients, neopterin concentrations were elevated, the declined after seroconversion, but still remained higher than the standard value. In the asymptomatic phase of infection, neopterin concentration in serum was moderately elevated, contrary to disease progression and AIDS, when definitely the highest values were observed. Such, the evaluation of neopterin concentration seems to be ideal for monitoring the course of HIV-1 infection (17, (42) (43) (44) (45) .
In another study, Okumara et al compared the serum concentrations of neopterin of 17 children with influenza virus type A and 17 healthy children aged 1-6 years (mean 2.4 years). The concentration of neopterin in children with influenza was significantly higher compared to the control group (23.8 ± 1.8 nmol/L vs. 14.1 ± 1.8 nmol/L) (46).
Niederwieser et al. reported the increased concentrations of the neopterin in the urine of more than 90% of children with viral infection (chicken pox, mumps, viral pharyngitis) and only in 14% of children with bacterial infection (pneumonia, meningitis). The authors concluded that neopterin is a non-specific parameter which only reflects the activation of cellular immune response (39) .
Graessle et al. evaluated neopterin concentration in urine of 45 children with bronchial asthma, 29 children with Rotavirus infection, 9 children with other viral infections, 5 children with bacterial infections and 29 healthy children (without evidence of infection). In asthma group, neopterin concentration in urine was low and similar with the control group. In all the children with symptomatic infection neopterin concentrations were significantly higher and the highest values were noted in children with Rotavirus infection (47).
Shaw et al. studied neopterin and CRP levels in patients with bacterial (Pneumococci, Staphylococci, Streptococci, E coli, Klebsiella, Pseudomonas, Salmonella, Meningococci) and viral (hepatitis A, CMV, EBV, rubella, parvovirus) infections (33) . Contrary to other researches, these authors found that neopterin concentration cannot be regarded as a differentiating parameter between these two types of infection. Thus, the chronicity of the infection and/or type of bacterium seems to be important whether neopterin concentrations increase or not in patients. However, the ratio of CRP: neopterin is helpful in differential diagnosis: if the ratio of CRP (mg/L) to a concentration of neopterin (nmol/L) is greater than 1, bacterial infection is probable, whereas a value below 1 is characteristic for the viral etiology (33) . Thus, serum neopterin can be used as a differentiating, monitoring and forecasting parameter in viral infections (4, 17, 18, 26, [48] [49] [50] .
Intracellular bacterial infections
Intracellular bacteria such as Mycobacterium tuberculosis, Mycobacterium leprae, Listeria monocytogenes, Salmonella and Brucella stimulate the cellmediated immune response (17, 18, (51) (52) (53) (54) (55) . Studies conducted in patients with pulmonary tuberculosis revealed that neopterin concentration correlates with the severity and activity of the disease. This phenomenon was also confirmed in children (56, 57) .
Parasitic diseases
The clinical usefulness of neopterin in parasitic diseases was also evaluated. It is known that even in mild course of malaria, the concentration of neopterin increases (58) . The highest concentrations of neopterin were achieved in patients with severe disease (59) . It is assumed that in 94% cases of Plasmodium falciparum infection, the disease and its treatment can be monitored by assessing the concentration of neopterin in the urine (20) . According to the international statistics, Plasmodium falciparum infection remains the primary cause of mortality in children. Taking this into consideration, the determination of the neopterin concentrations seems to be of great clinical value.
The utility of neopterin concentrations in the diagnosis of Giardia lamblia infection is not confirmed. It was observed that concentration of the neopterin in serum was low in the course of lambliasis and increased after the elimination of the pathogen (60) . However, according to another study, the determina-tion of neopterin concentrations in the feces is not clinically useful, although long-term height and weight gains were negatively associated with mean subject fecal neopterin concentrations (14) .
Infections of the central nervous system
Because neopterin penetrates the blood-brain barrier, there is a relationship between the concentration of neopterin in serum and in the CSF (61) . In meningitis, neopterin concentration in CSF is a more sensitive parameter than the concentration of the neopterin in serum (62) (63) (64) .
In patients with acute neuroborreliosis, neopterin concentration in CSF reached extremely high values (above 100 nmol/L). After appropriate treatment had been introduced, systematic decrease of the concentration of the neopterin was observed. At the same time, concentrations of neopterin in serum, both before and during therapy, remained constant within the normal ranges (22, 65, 66) .
Burns
Monitoring of neopterin concentrations in patients with burns facilitates quick recognition of developing infection. The studies conducted in recent years have revealed that concentrations of neopterin and the amount of endotoxin circulating in the blood, were significantly higher in burnt patients and corresponded with the size of the burnt area. The neopterin concentrations were also higher in patients who developed sepsis and who did not survive. It was hypothesized that the thermal burns induce the secretion of neopterin, and endotoxin present in the circulation may be responsible for maintaining this induction (67) (68) (69) .
Oral Diseases
Determination of neopterin concentration in saliva is also used in dentistry. It was found that locally (in saliva) increased neopterin secretion correlates with the severity of periodontal inflammatory diseases. Interestingly, at the same time there was no increase in the concentration of neopterin in the urine (31) . These results are promising and further studies on the usefulness of determining the neopterin concentration in saliva in daily dental practice, as a completely noninvasive methods are required.
Autoimmune Diseases
Neopterin concentration was studied in patients with autoimmune diseases such as: systemic lupus erythematosus (70), rheumatoid arthritis (RA) (71), Wegener's granulomatosis (72) , dermatomyositis (73, 74) , chronic inflammatory bowel diseases (IBD): Crohn's disease (75, 76) , ulcerative colitis (77) and celiac disease (18) . It is assumed that the concentration of neopterin corresponds with activity and severity of autoimmune process (48).
Reibnegger et al. evaluated the concentration of neopterin in the urine of patients with RA (71) . Although the authors found the test sensitive in monitoring the clinical course of the disease, the test was not specific. In addition, results of this study demonstrate that determining the concentration of neopterin may be used in differentiating diagnosis between RA and other, degenerative bones and joints diseases. Moreover, Maerker-Alzer et al. reported the highest concentrations of neopterin in synovial fluid during RA exacerbations (78) .
In other research, concentration of the neopterin in patients with RA during exacerbation and remission was studied. The authors found close relationship between the concentration of neopterin in the urine and the disease activity. Moreover, both ESR and CRP occurred to be clinically less useful. In addition, the latter two parameters were not correlated with neopterin concentration (79) .
Schroecksnadel et al. reported the positive correlation between serum concentrations of neopterin and RA severity estimated on the basis of the radiological changes according to Steinbrocker (80) . The results of the research conducted among children with juvenile dermartomyositis (aged 4 -17 years) revealed that neopterin concentration in the urine correlated well with disease activity and muscle function. In addition, determining of neopterin concentration might, as well, be used in predicting the disease course. Nevertheless, serum concentrations of neopterin did not correlated with enzymatic activity of lactate dehydrogenase (LDH), aspartate aminotransferase (AST), routinely determined in this condition (74) .
Neopterin concentration in urine is believed to be a useful parameter in monitoring the activity of inflammatory bowel diseases (IBD) such as Crohn's disease (75, 76) and ulcerative colitis (77) . Although neopterin concentrations in body fluids correspond with the IBD activity (both Crohn's disease and ulcerative colitis), the lack of specificity of this marker must be emphasized. Most researchers agree that it is advisable to evaluate the concentration of neopterin in parallel to other laboratory and clinical parameters in order to monitor inflammatory bowel disease activity (81).
However, Forrest described no differences in the concentration of neopterin in patients with IBD compared to the control group. It must be noted, that the number of patients in this project was small (5 patients with Crohn's disease and 7 ulcerative colitis) and almost all patients, except for one, were in remission (82) .
On the other hand, Propst et al. observed the existence of a positive correlation among neopterin, Creactive protein, alpha-1-glycoprotein and the receptor of IL-1 antagonist in sera of patients with Crohn's disease. These parameters correlated with the disease activity. In contrast, no such relations were observed in patients suffering from ulcerative colitis. These discrepancies were explained by different pathogenesis of these two types of IBD (83) .
Similar results were obtained by Duclos et al. In this study, including 65 adult patients with Crohn's disease and varying disease activity, higher values of neopterin in the serum of patients with more active (severe) disease were found. Additionally, the authors described a positive correlation between serum concentrations of neopterin and soluble receptor for interleukin-2 (sIL-2R). The latter is known as a parameter correlating with the activity of autoimmune diseases (84).
Granditsch also described a relationship between levels of neopterin in urine and the clinical activity of Crohn's disease both in children and adolescents. The study included 135 patients aged 9 to 19 years. In conclusion, the author distinguished neopterin out of the 23 data/parameters (collected from medical history, clinical examination and laboratory tests) as an independent parameter closely correlating with the course and disease activity (85) .
In another study, urinal neopterin concentration was confirmed to be independent indicator of clinical activity of Crohn's disease (86) .
Prior et al. also confirmed the great usefulness of determining the concentration of neopterin in the urine of patients with Crohn's disease. The authors observed a close correlation between the concentration of neopterin and disease duration, patients' body mass and the presence of abdominal tumor (in palpation). The authors found that the location and extension of affected site of gastrointestinal tract does not relate to the concentration of neopterin, while the appropriate treatment leads to a systematic, linear decrease of neopterin (75) .
Interestingly, Niederwieser et al. reported, that elevated concentration of neopterin in urine was observed in 100% of adult patients with severe ulcerative colitis, in 75% of those with moderate and none of the patients with mild disease (according to the Trullove-Witts scale) (77) . Another study concerned another autoimmune disease, namely celiac disease (18) . It was observed that concentrations of the neopterin in urine were significantly higher in patients during active disease and decreased when gluten-free diet was introduced.
Cancer
Neopterin is not a specific marker that allows diagnosis in oncology. The increasing neopterin concentration simply reflects stimulation of cellular immunity, which takes place in many different pathologies. Nevertheless, neopterin is known to be a very useful parameter in oncology. It has been observed that neopterin concentration correlates with tumor stage, the risk of metastases, recurrence and death (87) .
The prevalence of elevated concentrations of neopterin in serum or urine in patients at the time of diagnosis of neoplastic disease depends inter alia on the type of tumor. Higher concentrations are described in 20% of patients suffering from breast tumor or melanoma malignant up to 90% in hematologic malignancies (17, (88) (89) (90) (91) .
About 80% women with ovarian tumors have elevated levels of the neopterin at the time of diagnosis. Similarly, 70% of patients with pancreatic cancer, nearly 60% of people with lung tumors and 55% women with cervical cancer had higher neopterin concentrations compared to healthy group. Moreover, the value of neopterin concentration is dependent on the stage of malignancy. Generally it can be concluded that the more advanced malignancy the higher concentration of neopterin (88) . It was observed that after the treatment had been applied, concentration of neopterin decreased, sometimes even normalized. It must be noted, that the relationship between neopterin concentration in the urine and the approximate total tumor mass was reported as well. Some researchers suggested that evaluation of serum neopterin level might be clinically useful in differentiation of breast tumors. (92, 93) . In malignant conditions neopterin concentrations were higher compared to benign tumors.
The most spectacular is, probably, the fact that concentration of neopterin appears to be a significant and independent prognostic factor for survival in oncology. The relationship: "the higher concentration of neopterin, the worse prognosis" has already been proven for: haematopoetic (94), cervical (95) , ovarian (96) , colorectal (97) , lung (98, 99) , prostate (100) and liver malignances (101, 102) .
Monitoring of the neopterin level (especially in the urine, as a non-invasive method) may also be useful when oncological treatment is finished, since the increase of its concentration could reflect the relapse. Nevertheless, one should strongly emphasize that in most cases, well known markers of malignancy, which are produced by the particular cells, correlate better with tumor growth than the concentration of neopterin. However, neopterin is considered to be a better prognostic factor for patients' survival (17) .
Transplantology
Determination of neopterin concentration is widely used in transplantology. Unchanging or returning to normal after transplantation neopterin concentrations in serum and urine probably indicate uneventful postoperative course. The increasing concentration of neopterin precedes complications, specifically transplant rejection or infection (103) . It has been reported, that systematic measurements of neopterin allow to anticipate the kidney transplant rejection four days earlier than conventional methodologies (104) . Similar data on heart (105), liver (106) and pancreatic (107) transplant were published. However, it was noted that in these cases simultaneous evaluation of neopterin concentration in bile or pancreatic juice significantly increased the sensitivity of this test (108) .
In patients with bone marrow transplant, repeated measurements of neopterin level can predict graft versus host (GVH) disease or the viral infection development (109) .
Transfusiology
One of the greatest risks associated with blood transfusion is the risk of transmitting infectious diseases to the recipient. In order to avoid this, various screening tests have been performed. So far none of the available methods gives absolute diagnostic certainty. Moreover, one must be aware of so called "window period", the period of time when a pathogen is present in the blood but the concentration of the specific antibodies is not detectable by the available diagnostic tests (25) .
As it was previously discussed, neopterin is a nonspecific parameter, and its concentration increases in the whole range of infections, especially viral. Such, determination of neopterin concentration, as an indirect marker of infection, may help to reduce the risk of infection transmission.
Hoenlinger et al reported, that about 1.5% of 76 000 healthy blood donors had elevated concentration of neopterin (24) . In many of these patients, further analyses revealed cytomegalovirus or protozoan (Toxoplasma gondi) infection, with no clinical manifestations. The remaining blood donors with elevated neopterin concentration were diagnosed as infected with an unknown pathogen, and their blood was disqualified from transfusion. In another study, serological tests of blood samples, in which the concentration of neopterin was previously assessed as above 10 nmol/L, revealed cytomegalovirus, Epstein-Barr, Parvovirus B 19, and HCV infections (17) .
These data correspond with Turkish study from 2005, which included 2760 blood donors. The authors observed the serum concentration of neopterin equal to or above 11 nmol/L in 141 blood donors (5.1% of the study group). Further detailed studies allowed to identify a variety of viral infections, for example adenovirus infection in these subjects (40) . Screening tests of neopterin level in blood donors, not only allow to detect an infection by this completely non-specific method, but, as well, very effectively increase the safety of blood transfusion (17) .
In the Austrian Tyrol, in 1986, in compliance with legislation, in each blood sample concentration of neopterin was assessed before the transfusion. Currently (since 1994), all Austrian blood centers are obliged to perform neopterin evaluation, as a screening test.
Cardiovascular diseases
Increased concentrations of neopterin have been reported in coronary atherosclerosis (110) , thus indicating the role of inflammation in an advanced stage of this disease. The relationship between the visible angiographic lesions and the concentration of neopterin in serum of patients with unstable pectorial angina (angina pectoris) was proved (111) . Such, the neopterin may become a marker of coronary arteries disease activity. In this study, concentration of neopterin was determined as an independent prognostic risk factor of an adverse "cardiac events" (112, 113) .
Diseases of eldery, neurodegeneration
Many reports described an increase of neopterin concentration in healthy older people (114, 115) . This was the reason for the development of separate reference values of neopterin concentrations in this age group. However, further studies are required. It is known that neurodegenerative diseases are closely related with increased oxidative stress and stimulation of the immune system. Hence, in Alzheimer's disease, neopterin concentration increases in correlation with the deterioration of mental skills (116) (117) (118) .
Similar observations on neopterin levels were made in patients with Huntington's chorea (119) and Creutzfeldt-Jakob disease (120) . This phenomenon reflects the chronic stimulation of the immune system in these conditions and contributes to better understanding of their pathogenesis. It must be also noted, that high concentrations of the neopterin have been also reported in adults with Down's syndrome (121) .
Conclusions
Although the knowledge on biological role of neopterin has been developing, many issues remain to be elucidated. Relatively easy and not too expensive methods of neopterin evaluation in various biological fluids make this parameter very useful in quite many medical areas. To determine the exact role of neopterin in humans, certainly further studies are necessary. Currently, intensive studies are held concerning pointof-care testing, which are very promising for everyday clinical practice. 
